Search Results - "Shelby, Elena Silvia"
-
1
Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania
Published in PloS one (01-04-2021)“…We evaluated in this cohort study the predictive ability of 23 peripheral blood parameters and ratios for treatment outcomes after the 2-month intensive phase…”
Get full text
Journal Article -
2
Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I
Published in Journal of clinical medicine (26-11-2021)“…Background: Spinal muscular atrophy (SMA) is a neuromuscular progressive disease, characterized by decreased amounts of survival motor neuron (SMN) protein,…”
Get full text
Journal Article -
3
Risk of Death in Comorbidity Subgroups of Hospitalized COVID-19 Patients Inferred by Routine Laboratory Markers of Systemic Inflammation on Admission: A Retrospective Study
Published in Viruses (31-05-2022)“…Our study objective was to construct models using 20 routine laboratory parameters on admission to predict disease severity and mortality risk in a group of…”
Get full text
Journal Article -
4
INNOVATIVE THERAPIES IN GENETIC DISEASES: SPINAL MUSCULAR ATROPHY
Published in Revista română de pediatrie (30-06-2021)“…Spinal muscular atrophy is a congenital neuromuscular disease characterized by the deterioration of the motor neurons located mainly in the anterior horns of…”
Get full text
Journal Article -
5
Physical Therapy and Nusinersen Impact on Spinal Muscular Atrophy Rehabilitative Outcome
Published in Frontiers in bioscience (Landmark. Print) (01-06-2022)“…INTRODUCTIONSpinal muscular atrophy (SMA) is a progressive neurological disease with autosomal recessive transmission that affects motor neurons, causing their…”
Get full text
Journal Article -
6
Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy
Published in Medicina (Kaunas, Lithuania) (01-07-2023)“…The objective of our retrospective study was to investigate the changes in pNFH levels in cerebrospinal fluid, which is a reliable marker of neuronal damage,…”
Get full text
Journal Article -
7
Expanding the Clinical Phenotype of 19q Interstitial Deletions: A New Case with 19q13.32-q13.33 Deletion and Short Review of the Literature
Published in Genes (24-01-2022)“…19q13 microdeletion syndrome is a very rare genetic disease characterized by pre- and postnatal growth retardation, intellectual disability, expressive…”
Get full text
Journal Article -
8
Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results
Published in Pathogens (Basel) (22-06-2021)“…Pro-inflammatory mediators play an important role in the pathogenesis of pulmonary tuberculosis. Consecutively, 26 pulmonary tuberculosis patients were…”
Get full text
Journal Article -
9
Innovative therapies in genetic diseases: Cystic fibrosis
Published in Revista română de pediatrie (31-03-2021)“…Cystic fibrosis, also named mucoviscidosis, is the most frequent hereditary pulmonary disease and is produced by mutations in the CFTR gene, encoding an…”
Get full text
Journal Article -
10
Pathogenic Copy Number Variations Involved in the Genetic Etiology of Syndromic and Non-Syndromic Intellectual Disability-Data from a Romanian Cohort
Published in Diagnostics (Basel) (01-12-2022)“…The investigation of unexplained global developmental delay (GDD)/intellectual disability (ID) is challenging. In low resource settings, patients may not…”
Get full text
Journal Article -
11
1q44 microdeletion syndrome: A new case with potential additional features
Published in Practica medicală (2006) (31-03-2021)“…1q44 microdeletion syndrome (1q44 monosomy) is a newly described genetic syndrome characterized by the haploinsufficiency of a 6 Mb locus on the long arm of…”
Get full text
Journal Article -
12
Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency
Published in Journal of medicine and life (2021)“…Spinal muscular atrophy (SMA) is a spectrum of genetically and clinically heterogeneous diseases leading to the progressive degeneration of peripheric motor…”
Get full text
Journal Article -
13
Phenotypic manifestations of C5orf42 pathogenic variants
Published in Revista română de pediatrie (31-03-2022)“…Joubert syndrome is a genetic disease with an autosomal-recessive or X-linked inheritance pattern caused by pathogenic variants in at least 35 genes, all…”
Get full text
Journal Article -
14
Clinical and genetic aspects in the Ehlers Danlos syndrome
Published in Revista română de pediatrie (31-12-2020)“…Introduction. Ehlers Danlos syndrome is a group of hereditary diseases of the connective tissue with a combined prevalence of 1 in 5,000 cases which have in…”
Get full text
Journal Article -
15
Terapii inovative în bolile genetice: Fibroza chistică
Published in Revista română de pediatrie (31-03-2021)“…Fibroza chistică, numită și mucoviscidoză, este cea mai frecventă boală pulmonară ereditară și este produsă de mutații în gena CFTR, ce codifică un canal…”
Get full text
Journal Article -
16
OP-105 Early detection for improved outcomes in spinal muscular atrophy
Published in BMJ paediatrics open (11-07-2024)“…AimSpinal Muscular Atrophy (SMA) is a rare genetic disorder that causes muscle weakness and atrophy due to the impact on motor neurons in the spinal cord. It…”
Get full text
Journal Article -
17
Aspecte clinice şi genetice în cadrul sindromului Ehlers Danlos
Published in Revista română de pediatrie (31-12-2020)Get full text
Journal Article -
18
Aspecte clinice şi genetice în cadrul sindromului Ehlers Danlos
Published in Revista română de pediatrie (01-12-2020)“…Introducere. Sindromul Ehlers Danlos reprezintă un grup de boli ereditare ale țesutului conjunctiv, cu o prevalență combinată de 1 la 5.000 de cazuri ce au în…”
Get full text
Journal Article -
19
-
20